Option chain shows key data for Traws Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Traws Pharma.

Traws Pharma (NASDAQ:TRAW) Stock, Option Chain

Traws Pharma

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Konskie,,Poland,-,March,08,,2025:,Restoration,Hardware,Company,Logo

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADBE

BIAF

CGBS

EONR

FGEN

GNLN

HCTI

HUSA

INDO

NINE

PRZO

RNTX

RSLS

SBET

TPET

TRAW

USEG

VEON

Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Tallinn,,Estonia,-,August,4th,2023,-,Screen,With,Stock

Earnings

Equities

Eurozone

Intraday Update

CRDO

RBBN

TRVI

UNFI

Dow Gains Over 100 Points; US Job Openings Increase In April

Wall Street

HCAI

MCTR

MODV

NIVF

US Stocks Mixed; Dollar General Posts Upbeat Earnings

Traws Pharma Inc

TraWell Co SpA

Health Care

Press Releases

Traws Pharma's Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

Traws Pharma's COVID-19 Candidate, Ratutrelvir, Presented at ICAR

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates  Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET

Traws Pharma Announces Management Updates

Traws Pharma Reports Full Year 2024 Results and Business Highlights

Traws Pharma Reports First Quarter 2025 Results and Business Highlights

Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!

EYEN

IKNA

IOVA

KPRX

PNPNF

PRSO

SNYR

TSXV:PNPN

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Biofrontera

Clearmind Medicine

CNS Pharma

Cocrystal Pharma

China Pharma Holding

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Evoke Pharma

Impact BioMedical

IM Cannabis

Incannex Healthcare

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

NLS Pharmaceutics

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

Talphera

TherapeuticsMD

VYNE Therapeutics

cbdMD

Comments

Traws Pharma

Traws Pharma (TRAW) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell